 There are two treat to target goals: Clinical Remission as defined by a CDAI score of 2.8 for those patients who entered the study with a CDAI score of 22 and Low Disease Activity LDA as defined by a CDAI score of 10 for those who entered the study with a CDAI score of 22. 